V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016749 | 270009744 | 1.62 | 70.4 | Not known (9) | 2016-12-12 | 2016-12-29 | Vinblastine weekly | N | N | 270016785 | CISPLATIN + GEMCITABINE |
| 270016750 | 270009745 | 1.7 | null | Adjuvant (A) | 2014-10-25 | 2014-10-26 | Panitumumab | 02 | N | 270016786 | BEAM + ALEMTUZUMAB |
| 270016751 | 270009746 | 1.69 | 57 | Palliative (P) | 2016-10-01 | 2017-08-24 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 270016791 | IGEV |
| 270016752 | 270009747 | 1.55 | 58.3 | Palliative (P) | 2018-01-25 | 2018-05-31 | Bevacizumab 5mg/kg | 2 | N | 270016791 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270016753 | 270009751 | 1.57 | null | Disease modification (D) | 2016-06-29 | 2019-04-27 | GDP | 2 | N | 270016828 | GDP |
| 270016754 | 270009759 | 1.85 | 0 | Adjuvant (A) | 2018-08-17 | 2018-09-23 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 270016836 | PANITUMUMAB |
| 270016755 | 270009761 | 1.73 | 43 | Palliative (P) | 2017-09-29 | 2017-10-02 | GEM-P | N | N | 270016837 | GEMCITABINE + PACLITAXEL |
| 270016756 | 270014573 | null | 78.6 | Palliative (P) | 2018-02-01 | 2018-02-08 | BENDAMUSTINE | N | N | 270016840 | BENDAMUSTINE |
| 270016757 | 270017040 | 1.7 | 37 | Adjuvant (A) | 2017-09-14 | 2017-11-15 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | 02 | N | 270016843 | CETUXIMAB + OXALIPLATIN + MDG |
| 270016758 | 270014574 | 1.48 | 92.3 | Palliative (P) | 2017-02-09 | 2017-04-06 | Panitumumab | N | N | 270016851 | CARBOPLATIN |
| 270016759 | 270009765 | 1.7 | 68 | Palliative (P) | 2018-08-07 | 2019-01-31 | Cisplatin | N | N | 270016860 | GEMCITABINE |
| 270016760 | 270014576 | null | 95.6 | null | 2014-12-22 | 2014-12-24 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 270016872 | OXALIPLATIN + RALTITREXED |
| 270016761 | 270009768 | 1.82 | 63 | Palliative (P) | 2013-10-04 | 2013-10-04 | IVE | N | N | 270016880 | IVE |
| 270016762 | 270009771 | 1.32 | 111.7 | Adjuvant (A) | 2015-07-14 | 2016-07-31 | CARBOPLATIN | N | N | 270016883 | GEMCITABINE |
| 270016763 | 270009773 | 1.63 | 84 | Adjuvant (A) | 2014-10-21 | 2014-10-28 | Bevacizumab 5mg/kg | 2 | N | 270016885 | AFLIBERCEPT + FU + IRINOTECAN |
| 270016764 | 270009777 | 1.73 | 56 | Adjuvant (A) | 2014-10-01 | 2014-10-13 | Bevacizumab | 02 | N | 270016904 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270016765 | 270009779 | 1.6 | 107 | Curative (C) | 2017-08-12 | 2017-08-31 | BEAM + Alemtuzumab Allo SCT | N | N | 270016905 | OXALIPLATIN + RALTITREXED |
| 270016766 | 270009780 | 1.8 | 68.8 | Palliative (P) | 2014-06-05 | 2014-06-19 | Oxaliplatin + Raltitrexed | N | N | 270016910 | OXALIPLATIN + RALTITREXED |
| 270016768 | 270017048 | null | 93.4 | null | null | 2017-05-19 | Bendamustine + prednisolone | N | null | 270016922 | BENDAMUSTINE |
| 270016769 | 270009785 | 1.76 | 85.5 | Curative (C) | 2014-10-26 | 2014-11-02 | Irinotecan | 02 | N | 270016939 | IRINOTECAN |
| 270016770 | 270009787 | 1.8 | 110 | Neo-adjuvant (N) | 2015-11-02 | 2015-11-03 | R ABVD | N | N | 270016950 | OXALIPLATIN + RALTITREXED |
| 270016771 | 270009791 | null | null | Curative (C) | 2016-05-19 | 2016-06-05 | R ABVD | N | N | 270016955 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270016772 | 270009793 | null | 93.35 | Curative (C) | 2017-08-24 | 2017-08-26 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 270016956 | IGEV |
| 270016773 | 270009795 | 1.69 | 81.6 | Palliative (P) | 2015-05-18 | 2016-01-29 | Cisplatin | N | N | 270016962 | CISPLATIN |
| 270016774 | 270009797 | 1.66 | null | Adjuvant (A) | 2015-04-16 | 2015-05-01 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 270016962 | CARBOPLATIN |
| 270016775 | 270009798 | 1.63 | 99.2 | null | 2016-12-25 | 2017-01-02 | Oxaliplatin + Raltitrexed | N | N | 270016967 | CETUXIMAB + OXALIPLATIN + MDG |
| 270016776 | 270009801 | 0 | 122.1 | Adjuvant (A) | 2018-08-16 | 2018-08-22 | NIVOLUMAB | N | N | 270016977 | BEAM + ALEMTUZUMAB |
| 270016777 | 270014591 | null | 76 | Palliative (P) | 2016-09-06 | 2016-09-11 | GEM-P | N | N | 270016981 | GEMCITABINE + PACLITAXEL |
| 270016778 | 270009802 | 1.83 | 68.8 | null | 2018-11-02 | 2018-11-12 | IGEV | N | N | 270016987 | NIVOLUMAB |
| 270016779 | 270009804 | 1.7 | 70 | Curative (C) | 2016-08-30 | 2018-03-10 | Carboplatin AUC 2 - 5 | 2 | N | 270016989 | ABVD R |
| 270016780 | 270017055 | 0 | 106 | Palliative (P) | 2016-09-26 | 2016-09-26 | IVE | 2 | N | 270016997 | IVE |
| 270016781 | 270009813 | 1.78 | 72.9 | Palliative (P) | 2016-09-11 | 2016-10-18 | AFLIBERCEPT + FU + IRINOTECAN | null | N | 270017000 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270016782 | 270009817 | 1.69 | 51 | Adjuvant (A) | 2014-03-11 | 2014-03-11 | GEM-P | 02 | N | 270017008 | GEMCITABINE + PACLITAXEL |
| 270016783 | 270009819 | 1.69 | 70.3 | null | 2015-07-27 | 2015-08-12 | Cisplatin | N | N | 270017013 | PANITUMUMAB |
| 270016784 | 270009821 | 1.55 | null | Adjuvant (A) | 2014-07-29 | 2014-08-15 | IVE | N | N | 270017016 | IVE |
| 270016785 | 270009823 | null | 63.2 | null | 2014-11-07 | 2014-11-25 | Cyclophosphamide High Dose | N | N | 270017017 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270016786 | 270009826 | 1.59 | 83.8 | Curative (C) | 2013-08-13 | 2013-08-27 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 270017022 | CISPLATIN + GEMCITABINE |
| 270016787 | 270009829 | 1.74 | 85.3 | null | 2015-12-04 | 2015-12-11 | Irinotecan 14day | N | N | 270017028 | IRINOTECAN |
| 270016788 | 270009830 | 1.6 | 69.5 | Adjuvant (A) | 2011-11-01 | 2014-01-16 | Bevacizumab 5mg/kg | N | N | 270017039 | AFLIBERCEPT + FU + IRINOTECAN |
| 270016789 | 270009833 | 1.78 | 72.2 | Curative (C) | 2014-11-08 | 2015-04-30 | Irinotecan 14day | N | N | 270017039 | IRINOTECAN |
| 270016790 | 270009838 | 1.52 | 59.9 | Disease modification (D) | 2016-02-13 | 2016-02-16 | GDP | 1 | null | 270017051 | GDP |
| 270016791 | 270009843 | 1.75 | 105.3 | Palliative (P) | 2015-09-20 | 2015-09-29 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 270017056 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270016792 | 270009846 | 1.71 | 66.7 | null | 2014-10-26 | 2015-01-27 | Oxaliplatin + Raltitrexed | 02 | N | 270017059 | CETUXIMAB + OXALIPLATIN + MDG |
| 270016793 | 270009847 | 1.79 | 68.3 | Palliative (P) | null | 2018-07-06 | VEPEMB | null | Y | 270017063 | AFLIBERCEPT + FU + IRINOTECAN |
| 270016794 | 270009854 | 1.8 | null | Palliative (P) | 2018-09-08 | 2018-09-13 | R ABVD | N | N | 270017065 | OXALIPLATIN + RALTITREXED |
| 270016795 | 270009857 | null | 96.1 | Curative (C) | 2014-09-28 | 2014-11-20 | Cisplatin 7 day | N | null | 270017076 | VINBLASTINE |
| 270016796 | 270009859 | 1.73 | 83.1 | null | 2016-05-15 | 2016-05-19 | GEM-P | N | N | 270017085 | GEMCITABINE + PACLITAXEL |
| 270016797 | 270009863 | 1.78 | 121.7 | Palliative (P) | 2015-03-05 | 2015-03-09 | Bevacizumab 5mg/kg | 02 | N | 270017100 | ABVD R |
| 270016798 | 270014615 | 1.85 | null | null | 2015-10-02 | 2015-10-08 | Panitumumab | 02 | N | 270017102 | VINBLASTINE |
| 270016799 | 270009866 | null | 88.8 | null | 2013-12-21 | 2015-04-04 | BEAM + Alemtuzumab Allo SCT | N | N | 270017104 | GEMCITABINE |